Dr. Condie Carmack has over 30 years of experience in the life sciences and diagnostic industries, having been prior to GenomOncology the Director of Oncology Programs at Vela Diagnostics, developing an NGS-based system for worldwide regulatory approval, and prior to that helped found (as General Manager) the Cancer Genetics Laboratory at Baylor College of Medicine with Dr. Marilyn Li.

In 2011, the National Academy of Science published the results of a year-long committee effort called ‘Toward Precision Medicine: Building a Knowledge Network for Biomedical Research and a New Taxonomy of Disease’. This committee was charged to explore the feasibility and need to develop a new taxonomy of human disease based upon molecular biology, with the concept that with an explosion of molecular data about individuals with disease, there was a great untapped opportunity to use these data to improve health. FLICKR, JOHN GOODE

In this video interview, SeraCare’s Chief Scientific Officer Dr. Russell Garlick shares some background about SeraCare’s history of manufacturing controls and reference materials for infectious disease diagnostics, and how advances in Precision Medicine reveal a need for similar materials for the fields of oncology and maternal health.

You are a translational research scientist, clinical pathologist, or laboratory test developer, always on the lookout for new tools, best practices, the latest news, and quality information. Your daily work impacts people’s heath, which is why you entered the field in the first place, and you have seen tremendous change in the past few years with breakthrough genomic technology increasingly blurring the lines between research and ‘the clinic’.